Trajectory of extracellular fluid volume over time and subsequent risks of end-stage kidney disease and mortality in chronic kidney disease: a prospective cohort study

Archive ouverte

Faucon, Anne Laure | Leffondré, Karen | Flamant, Martin | Metzger, Marie | Boffa, Jean Jacques | Haymann, Jean Philippe | Houillier, Pascal | Thervet, Éric | Vrtovsnik, François | Proust-Lima, Cécile | Stengel, Bénédicte Né Dicte | Vidal-Petiot, Emmanuelle | Geri, Guillaume

Edité par CCSD ; Wiley -

International audience. Background: Extracellular fluid volume (ECF) is independently associated with chronic kidney disease (CKD) progression and mortality in patients with CKD, but the prognostic value of the trajectory of ECF over time beyond that of baseline value is unknown. Objectives: To characterize ECF trajectory and evaluate its association with the risks of end-stage kidney disease (ESKD) and mortality. Methods: From the prospective tricentric NephroTest cohort, we included 1588 patients with baseline measured glomerular filtration rate (mGFR) ≥15 mL min−1/1.73 m2 and ECF measurement. ECF and GFR were measured repeatedly using the distribution volume and clearance of 51Cr-EDTA, respectively. ESKD and mortality were traced through record linkage with the national registries. Adjusted shared random-effect joint models were used to analyse the association between the trajectory of ECF over time and the two competing outcomes. Results: Patients were mean age 58.7 years, 66.7% men, mean mGFR of 43.6 ± 18.6 mL min−1/1.73 m2 and mean ECF of 16.1 ± 3.6 L. Over a median follow-up of 5.3 [IQR: 3.0;7.4] years, ECF increased by 136 [95%CI 106;167] mL per year on average, whilst diuretic prescription and 24-hour urinary sodium excretion remained stable. ESKD occurred in 324 (20.4%) patients, and 185 (11.6%) patients died before ESKD. A higher current value of ECF was associated with increased hazards of ESKD (adjusted hazard ratio [aHR]: 1.12 [95%CI 1.06;1.18]; P < 0.001 per 1 L increase in ECF), and death before ESKD (aHR: 1.10 [95%CI 1.04;1.17]; P = 0.002). Conclusions: The current value of ECF was associated with the risks of ESKD and mortality, independent of multiple potential confounders, including kidney function decline. This highlights the need for a close monitoring and adjustment of treatment to avoid fluid overload in CKD patients.

Consulter en ligne

Suggestions

Du même auteur

Le bilan du sodium : nouveaux aspects

Archive ouverte | Faucon, Anne-Laure | CCSD

International audience. Le sodium est majoritairement présent dans le compartiment liquidien extra-cellulaire. La quantité totale de sodium échangeable présente dans l’organisme détermine le volume extracellulaire e...

Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease

Archive ouverte | Faucon, Anne-Laure | CCSD

International audience. Volume overload has been shown to be an independent risk factor for mortality in patients receiving chronic dialysis, but data in non-dialysis patients are scarce. Therefore we evaluated the ...

A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality

Archive ouverte | Faucon, Anne Laure | CCSD

International audience. It is unknown whether initiating diuretics on top of renin-angiotensin system inhibitors (RASi) is superior to alternative antihypertensive agents such as calcium channel blockers (CCBs) in p...

Chargement des enrichissements...